SAFLUTAN 15 micrograms/ml eye drops, solution, in single-dose container

Country: United Kingdom

Language: English

Source: myHealthbox

Active ingredient:

tafluprost

Available from:

Santen Oy

ATC code:

S01EE05

INN (International Name):

tafluprost

Dosage:

15 micrograms

Pharmaceutical form:

Eye drops, solution in single-dose container

Administration route:

ocular route

Units in package:

30 x 0.3 ml single-dose containers and 90 x 0.3 ml single-dose containers

Prescription type:

POM - Prescription Only Medicine

Manufactured by:

Laboratoire Unither

Therapeutic group:

Antiglaucoma preparations and miotics, prostaglandin analogues

Therapeutic indications:

Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension. As adjunctive therapy to beta-blockers

Authorization status:

Authorised

Authorization date:

2015-07-31

Patient Information leaflet

Profile: 
BO_200x280_EMO_Unither
Profile Revision: 
1
Profile Revision Date:  261109
Dimensions (mm): 
200 x 280 mm
Black
Technical Info
65NOT2520/G
270215-3
65NOT2520/G
461274A03
Profile
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
SAFLUTAN® 15 MICROGRAMS/ML
EYE DROPS, SOLUTION IN SINGLE 
DOSE-CONTAINER
Tafluprost
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE 
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
•  Keep this leaflet. You may need to read it again.
•  If you have any further questions, ask your doctor, pharmacist
or 
nurse.
•  This medicine has been prescribed for you only. Do not pass it
on to 
others. It may harm them, even if their signs of illness are the
same 
as yours.
•  If you get any side effects, talk to your doctor, pharmacist or
nurse. 
This includes any possible side effects not listed in this leaflet. 
See section 4.
WHAT IS IN THIS LEAFLET:
1.  What SAFLUTAN is and what it is used for
2.  What you need to know before you use SAFLUTAN
3.  How to use SAFLUTAN
4.  Possible side effects
5.  How to store SAFLUTAN
6.  Contents of the pack and other information
1.  WHAT SAFLUTAN IS AND WHAT IT IS USED FOR
WHAT KIND OF MEDICINE IS IT AND HOW DOES IT WORK?
SAFLUTAN eye drops contain tafluprost, which belongs to a group 
of medicines called prostaglandin analogues. SAFLUTAN lowers the 
pressure in the eye. It is used when the pressure in the eye is too
high.
WHAT IS YOUR MEDICINE FOR?
SAFLUTAN is used to treat a type of glaucoma called open angle
glaucoma 
and also a condition known as ocular hypertension in adults. Both of
these 
conditions are linked with an increase in the pressure within your eye
and 
eventually they may affect your eyesight.
2.  WHAT YOU NEED TO KNOW BEFORE YOU USE SAFLUTAN
DO NOT USE SAFLUTAN:
•  if you are allergic to tafluprost or any of the other
ingredients of this 
medicine (listed in section 6).
WARNINGS AND PRECAUTIONS
Talk to your doctor, pharmacist or nurse before using SAFLUTAN.

Summary of Product characteristics

6$)/87$1PLFURJUDPVPOH\HGURSVVROXWLRQ
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_6DQWHQ8./LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
6$)/87$1ŠPLFURJUDPVPOH\HGURSVVROXWLRQLQVLQJOHGRVHFRQWDLQHU
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
2QHPORIH\HGURSVVROXWLRQFRQWDLQVPLFURJUDPVRIWDIOXSURVW
2QHVLQJOHGRVHFRQWDLQHUPORIH\HGURSVVROXWLRQFRQWDLQVPLFURJUDPVRIWDIOXSURVW
2QHGURSDERXW—OFRQWDLQVDERXWPLFURJUDPVRIWDIOXSURVW
)RUWKHIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
(\HGURSVVROXWLRQLQVLQJOHGRVHFRQWDLQHUH\HGURSV
$FOHDUFRORXUOHVVVROXWLRQ
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
5HGXFWLRQRIHOHYDWHGLQWUDRFXODUSUHVVXUHLQRSHQDQJOHJODXFRPDDQGRFXODUK\SHUWHQVLRQ
$VPRQRWKHUDS\LQSDWLHQWV
RZKRZRXOGEHQHILWIURPSUHVHUYDWLYHIUHHH\HGURSV
RLQVXIILFLHQWO\UHVSRQVLYHWRILUVWOLQHWKHUDS\
RLQWROHUDQWRUFRQWUDLQGLFDWHGWRILUVWOLQHWKHUDS\
$VDGMXQFWLYHWKHUDS\WREHWDEORFNHUV
6$)/87$1LVLQGLFDWHGLQDGXOWV•\HDUV
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
3RVRORJ\
7KHUHFRPPHQGHGGRVHLVRQHGURSRI6$)/87$1LQWKHFRQMXQFWLYDOVDFRIWKHDIIHFWHGH\HVRQFHGDLO\LQWKH
HYHQLQJ
7KHGRVHVKRXOGQRWH[FHHGRQFHGDLO\DVPRUHIUHTXHQWDGPLQLVWUDWLRQPD\OHVVHQWKHLQWUDRFXODUSUHVVXUHORZHULQJ
HIIHFW
)RUVLQJOHXVHRQO\RQHFRQWDLQHULVVXIILFLHQWWRWUHDWERWKH\HV$Q\XQXVHGVROXWLRQVKRXOGEHGLVFDUGHGLPPHGLDWHO\
DIWHUXVH
_8VHLQHOGHUO\_
1RGRVDJHDOWHUDWLRQLQHOGHUO\SDWLHQWVLVQHFHVVDU\
_3DHGLDWULFSRSXODWLRQ_
7KHVDIHW\DQGHIILFDF\RIWDIOXSURVWLQFKLOGUHQEHORZDJHKDVQRW\HWEHHQHVWDEOLVKHG1RGDWDDUHDYDLODEOH
_8VHLQUHQDOKHSDWLFLPSDLUPHQW_
7DIOXSURVWKDVQRWEHHQVWXGLHGLQSDWLHQWVZLWKUHQDOKHSDWLFLPSDLUPHQWDQGVKRXOGWKHUHIRUHEHXVHGZLWKFDXWLRQLQ
VXFKSDWLHQWV
0HWKRGRIDGPLQLVWUDWLRQ
7RUHGXFHWKHULVNRIGDUNHQLQJRIWKHH\HOLGVNLQWKHSDWLHQWVVKRXOGZLSHRIIDQ\H[FHVVVROXWLRQIURPWKHVNLQ$V
ZLWKDQ\RWKHU